StockData
Regentis Biomaterials Ltd. logo

Regentis Biomaterials Ltd. (RGNT) stock

RGNTNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 24, 2026Score 1/30
$1.14−0.08 (-6.56%)

Close on Nov 18, 2026Market cap $5.90MP/E –Yield –

Regentis Biomaterials net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2025 it was -$13.65M, down 384.3% from the year before.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$13.65M-384.3%
FY2024Dec 31, 2024$4.80M–
FY2023Dec 31, 2023-$4.13M–

More Regentis Biomaterials figures

See a number that looks wrong?